Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Britain's biotech potential (part I): world-class science, second-class support? The UK produces top-tier life sciences research, offers favourable conditions for early-stage investment and hosts a growing network of internationally competitive clusters. So...
  2. NEUVIOR Pharmaceuticals receives Innovate UK grant to explore bio-based materials for circular pharmaceutical manufacturing The Innovate UK feasibility grant will advance its ZYLON programme, which involves clean-chemistry lab trials exploring how bio-derived materials could replace...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Britain's biotech potential (part II): world-class science, second-class support? In part one, Manufacturing Chemist explored the UK’s world-class science base and early-stage investment appeal. In this second instalment, attention turns to the structural...
  4. Alcami to acquire contract packaging specialist Tjoapack in first European expansion The agreement will create a transatlantic platform with US-Europe supply chain redundancy spanning primary and secondary packaging, drug product manufacturing and...
  5. Awen Oncology secures seven-figure funding to advance rare bone cancer therapeutic programme The cancer therapeutics company has secured seven-figure funding led by biotech investor Dr Urs Spitz to progress its lead programme targeting a rare form of bone cancer with...

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Finance In part one, Manufacturing Chemist explored the UK’s world-class science base and early-stage investment appeal. In this second instalment, attention turns to the structural...

Britain's biotech potential (part II): world-class science, second-class support?

Read more
Finance The firm will acquire Organon in an all-cash $11.75bn transaction, creating a larger global pharma group with expanded manufacturing capacity, stronger women's health...

Sun Pharma to acquire Organon in $11.75bn deal, expanding global manufacturing and biosimilars reach

Read more
Finance Total UK biotech equity financing reached £552m in the first quarter of 2026, driven by a 17% quarterly rise in venture capital investment, according to BioIndustry...

UK biotech venture capital rises 17% in Q1 2026 as deal activity surges 67% year-on-year, BIA figures show

Read more
Regulatory The UK produces top-tier life sciences research, offers favourable conditions for early-stage investment and hosts a growing network of internationally competitive clusters. So...

Britain's biotech potential (part I): world-class science, second-class support?

Read more
Research & Development The Innovate UK feasibility grant will advance its ZYLON programme, which involves clean-chemistry lab trials exploring how bio-derived materials could replace...

NEUVIOR Pharmaceuticals receives Innovate UK grant to explore bio-based materials for circular pharmaceutical manufacturing

Read more
Research & Development The cancer therapeutics company has secured seven-figure funding led by biotech investor Dr Urs Spitz to progress its lead programme targeting a rare form of bone cancer with...

Awen Oncology secures seven-figure funding to advance rare bone cancer therapeutic programme

Read more
Packaging The agreement will create a transatlantic platform with US-Europe supply chain redundancy spanning primary and secondary packaging, drug product manufacturing and...

Alcami to acquire contract packaging specialist Tjoapack in first European expansion

Read more
Finance The company has completed its purchase of the Canada-based biopharma for $950m, handing it a drug that is a potentially “best-in-class” therapy for blood pressure diseases...

GSK completes acquisition of 35Pharma, gaining pulmonary hypertension candidate

Read more
Research & Development The pair have entered into an exclusive licensing agreement which grants AbbVie global rights outside mainland China to develop and commercialise its portfolio of novel pain...

Haisco licenses novel pain compounds to AbbVie in deal worth up to $745 million

Read more
Manufacturing US contract manufacturing deals for FDA-approved drugs hit a five-year low in 2025, as biopharma companies (including major US-headquartered firms) increasingly direct...

Biopharma firms favour European contract manufacturing over US sites despite tariff pressure

Read more
Research & Development Irish biotech consultancy Applied Biopharm Consulting has secured an Innovation Voucher from the Local Enterprise Office Cork North & West to collaborate with an academic...

Applied Biopharm Consulting awarded Innovation funding to validate AI-powered AAV vector engineering platform

Read more
Finance The addition enhances Lupin's presence in Europe and includes a portfolio of more than 60 innovative eye health products, backed by a well-established commercial infrastructure

Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio

Read more
Manufacturing BASF Pharma Solutions has implemented an immediate global price adjustment of up to 20% across its pharmaceutical excipients and selected active pharmaceutical ingredients...

BASF announces up to 20% price increase on pharmaceutical excipients and selected APIs

Read more
Research & Development An international collaboration spanning the universities of Exeter, Edinburgh and Cape Town has secured £4.5m to develop specialist bioimaging tools for WHO-priority fungal...

University of Exeter leads £4.5m Wellcome-funded initiative to develop bioimaging tools for fungal pathogens

Read more
Finance The purchase is the third multibillion-dollar acquisition for the pharma giant in the past year, as it moves to bolster its cancer portfolio ahead of its best-selling drug...

Merck to acquire cancer biotech Terns Pharmaceuticals for $6.7bn

Read more
Finance Strategic UK investment in next-generation cancer diagnostics and cardiovascular research training is accelerating innovation, reducing barriers to adoption and building the...

Investing in the future of healthcare: from diagnostics innovation to scientific talent pipelines

Read more